Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
The adaptive immune system's capacity to recognize a virtually limitless array of antigens is fundamentally dependent on the combinatorial and junctional diversity of the B-cell receptor (BCR) repertoire. Central to this diversity are the variable (V), diversity (D), and joining (J) gene segments that undergo somatic recombination. The germline-encoded V gene segment, in particular, exhibits a remarkable degree of polymorphism, with a vast number of alleles existing within the human population.
Uncover Hidden Ig V Alleles. .
Despite the critical role of these polymorphisms, our understanding remains incomplete. Existing immunogenetics databases, while foundational, are far from exhaustive, containing only a fraction of the true allelic diversity present across different human populations.
| Source of Variation | Description | Consequence |
| Germline polymorphisms | Inherited allelic differences | True novel Ig V alleles |
| Somatic hypermutation (SHM) | Programmed point mutations during affinity maturation | Potential false positives if misclassified |
Conventional methods, which rely on frequency-based filtering or simple comparison against reference databases, often lack the sensitivity and specificity to resolve this ambiguity.
To address this unmet need, Creative Biolabs has developed a specialized service for high-fidelity, automated identification of novel Ig V alleles from BCR repertoire data, empowering researchers to explore the full landscape of human immune diversity.
Our Novel Allele Identification service is built upon a state-of-the-art, high-throughput sequencing platform meticulously optimized for immune repertoire analysis. Recognizing that the quality of bioinformatic inference is inextricably linked to the quality of the raw sequencing data, we have engineered an integrated ecosystem that ensures maximum fidelity, depth, and consistency from sample receipt to data delivery. Key features of our platform include:
Every sample undergoes stringent quality assessment at multiple checkpoints, including nucleic acid quantification and integrity analysis, to guarantee that only high-quality material proceeds to library preparation.
Our proprietary protocols are designed to minimize amplification bias and sequencing errors, preserving the original quantitative and qualitative characteristics of the BCR repertoire.
We provide tailored sequencing depth to ensure comprehensive capture of the repertoire's complexity, enabling the robust statistical analysis required for distinguishing germline variants from somatic mutations.
The platform is engineered for large-scale projects, capable of processing hundreds of samples in parallel, making it ideally suited for population-level studies and comprehensive cohort analyses.
This powerful sequencing foundation provides the high-quality, large-scale datasets that are the essential substrate for our proprietary downstream bioinformatic analysis pipeline.
Go Beyond Databases — Identify Novel BCR Variants with Confidence. .
The core of our offering is the BCR Repertoire Analysis Service for Novel Allele Identification, an automated, multi-layered analytical workflow that transcends the limitations of conventional database-matching approaches. This service integrates sophisticated bioinformatics with immunogenetic principles to deliver unparalleled accuracy in allele discovery.
The technology is engineered to differentiate the stochastic and context-dependent signatures of SHM from the stable, heritable patterns characteristic of a germline polymorphism. It achieves this by:
The algorithm analyzes the distribution, frequency, and contextual biases of mutations across the entire dataset, identifying characteristic SHM hotspots and cold spots.
It then searches for nucleotide differences that are consistently present across multiple independent B-cell lineages within the same individual. A true novel allele is expected to be present as a stable, non-random variant, whereas SHM events are typically more variable and clonally restricted.
This process is further enhanced by an integrated Ig genotype determination step. By analyzing the V gene sequences from numerous B cells derived from a single donor, the service confirms whether a candidate variant is consistently inherited across the repertoire, providing definitive evidence that it represents a germline allele rather than a random mutational event. This integrated, automated workflow ensures a rigorous, objective, and highly accurate identification of novel Ig V alleles.
Turn Complex Repertoire Data into Clear Answers. .
The accurate identification of novel Ig V alleles has profound implications across the spectrum of biomedical research, from fundamental immunology to clinical therapeutics. Our service provides the critical data foundation for advancements in several key areas:
Fundamental Immunogenetics
Researchers can use this service to significantly expand and refine public Ig V gene databases, contributing to a more complete and accurate map of human immunogenetic diversity. This enables deeper investigations into the evolutionary pressures shaping the immune system and the population-specific distribution of Ig alleles across different ethnic and geographic groups.
Clinical and Translational Research
Novel V alleles may be directly associated with disease susceptibility or resistance. Our service facilitates studies aiming to link specific alleles to autoimmune conditions (e.g., rheumatoid arthritis, systemic lupus erythematosus), differential responses to infectious agents (e.g., HIV, influenza), or the capacity for tumor immune evasion. Such findings can lead to the discovery of novel diagnostic biomarkers and the identification of patient populations likely to respond to specific immunotherapies.
Antibody Drug Discovery and Engineering
The human immune system is the ultimate antibody engineer. Novel Ig V alleles represent a rich, untapped resource of naturally optimized antibody frameworks. These alleles may encode variable domains with unique structural features, enhanced stability, or the ability to target novel epitopes. By identifying these sequences, researchers can leverage them as templates for designing next-generation therapeutic antibodies with superior efficacy and developability profiles.
Discover Alleles That Conventional Methods Miss. .
Creative Biolabs' service is distinguished by a unique combination of technological innovation and operational excellence, offering a superior solution to the challenges of novel allele discovery.
Automated and Reproducible Analysis
Our proprietary, fully automated pipeline eliminates the subjective biases and potential errors associated with manual data analysis. This ensures exceptional reproducibility and provides results with the highest degree of confidence.
Efficiency and Scalability
By combining a high-throughput sequencing platform with a streamlined analytical workflow, we deliver results on an accelerated timeline. This efficiency makes our service highly suitable for large-scale screening projects, such as population genetics studies or clinical cohort analyses, that would be infeasible with traditional methods.
Unparalleled Technical Accuracy
The core strength of our service lies in its sophisticated algorithmic approach. The unique ability to analyze mutational patterns and integrate genotype determination allows for the definitive separation of true novel alleles from SHM artifacts—a critical distinction that other methods fail to make reliably.
Integrated, Cost-Effective Solution
We offer a comprehensive, end-to-end service that encompasses every step from sample processing and sequencing to advanced bioinformatic analysis and results interpretation. This integrated model provides exceptional value and makes cutting-edge immunogenetic research accessible to laboratories of all sizes.
Explore the Full Landscape of Immune Diversity. .
From Ambiguity to Clarity: High-Fidelity Novel Allele Identification. .
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
